86
86
Mar 16, 2015
03/15
by
FBC
tv
eye 86
favorite 0
quote 0
lipitor and those drugs, heart disease number one killer, this could be huge. >> i 10 to take a -- tend to take a preventive look at health care. and yes, you are right, i think here in united states people tend to help the problem when when they see symptoms, it will be a huge disrupter, however, i grew up with two parents who are doctors, all about preventive. i think in terms of that, i feel as we go forward, united states and consumer probably take a more preventive measure, exerciseing more. >> people are too lazy. >> look at people are geting on board. >> this is number one killer among women, not a family touched by cancer or heart disease we're worried about collapseing aning because of fod we're eating. tom: then you live to, the oldest lady is 114. i thousan thought do i want to t long. >> i don't have enough money to live that long. >> men are not going to live to 114, women are. tom: if you live too long we get always all alzheimer's a spend e this much on research for alzheimer's compared to other diseases, but doctors, lipitor, doctors have been preaching like a holy grail
lipitor and those drugs, heart disease number one killer, this could be huge. >> i 10 to take a -- tend to take a preventive look at health care. and yes, you are right, i think here in united states people tend to help the problem when when they see symptoms, it will be a huge disrupter, however, i grew up with two parents who are doctors, all about preventive. i think in terms of that, i feel as we go forward, united states and consumer probably take a more preventive measure,...
54
54
Mar 16, 2015
03/15
by
FBC
tv
eye 54
favorite 0
quote 0
, he has bad knees and apparently lipitor, one of the problems with the statins, they hit you in theoints that is not a good thing. would your drug, would this particular drug have fewer of those kind of bad side-effects than the traditional statins. >> we've specifically studied that type of patient in our study we called alternative. for patients who have not been previously been able to tolerate statins, we've been able to show that patients are able to have fewer muscle events when they're able, when they're treated with it instead after rechallenge with a drug like lipitor. david: the answer is question, they have fewer side-effects that than traditional statins? >> we've seen fewer side-effects than people using previous statins there. we've send well-come tolerated after the program. >> doctor, when i get home i want to eat cheese, you name it, i want to eat it. if i take this drug can i then eat foods i know are not good for my cholesterol? >> no. the first thing you need to do is actually be on a good diet, i'm sorry. the mainstay as we know has been statins. that has done a
, he has bad knees and apparently lipitor, one of the problems with the statins, they hit you in theoints that is not a good thing. would your drug, would this particular drug have fewer of those kind of bad side-effects than the traditional statins. >> we've specifically studied that type of patient in our study we called alternative. for patients who have not been previously been able to tolerate statins, we've been able to show that patients are able to have fewer muscle events when...
176
176
Mar 16, 2015
03/15
by
BLOOMBERG
tv
eye 176
favorite 0
quote 1
it is unlikely that anybody has the lean time that limit tour -- lipitor have. obviously, is going to make a lot of money. betty: how much? olivia: we just all the price forecast for it depends on what the indications are. the companies are concerned with the way that they would go and request for communications. initially these drugs will only the to patients for whom the statins are actually working. the idea is that over time these trials will send the usage in the patient population. these trials are not definitive and they're both working on multi-your trials that will come out over the next several years. betty: and results? these results were published in the new england journal of medicine. are they the final word? olivia: they are not the final world but they will bolster the case for insurers to cover them. there's going to be a lot of competition among the chug companies which is going to betty: mean that they lose pricing power. betty:betty: olivia sterns on some new drugs. ♪ betty: moving and shaking this hour. uncle sam has run up against the legal
it is unlikely that anybody has the lean time that limit tour -- lipitor have. obviously, is going to make a lot of money. betty: how much? olivia: we just all the price forecast for it depends on what the indications are. the companies are concerned with the way that they would go and request for communications. initially these drugs will only the to patients for whom the statins are actually working. the idea is that over time these trials will send the usage in the patient population. these...
191
191
Mar 16, 2015
03/15
by
KTVU
tv
eye 191
favorite 0
quote 0
taking the drugs had half the risk of dieing or suffering a heart problem compared to those that took lipitorre is needed about side effects >> you may not know it, burr today is international good deeds day, a call to action for people to lend a helping hand to someone in need or help their community. the tradition was launched back in 2007 and organizers say every good deed counts. >> volunteering at a soup kitchen, it could be taking a school and giving it a bit of a face-lift, painting it, doing gardening. it could be something personal and small. >> organizers say they have hundreds of thousands of volunteers from more than 50 countries and they hope the spirit of giving back continues to grow. >> getting advice on hackers from a third grader. coming up, details on the cyber security conference that hired a nine-year-old as their key popular vote speaker >> how much longer will the mild weather stick around in mark tomeo will be here with a look at your workweek forecast. a nine-year-old cyber security expert is showing crowds how easy it is for hackers to break into your smart phone or
taking the drugs had half the risk of dieing or suffering a heart problem compared to those that took lipitorre is needed about side effects >> you may not know it, burr today is international good deeds day, a call to action for people to lend a helping hand to someone in need or help their community. the tradition was launched back in 2007 and organizers say every good deed counts. >> volunteering at a soup kitchen, it could be taking a school and giving it a bit of a face-lift,...
173
173
Mar 16, 2015
03/15
by
CNBC
tv
eye 173
favorite 0
quote 0
even with lipitor.y. >> well, that's the problem with the blood clot drugs. people are worried about that with brilinta. and then there was news on devices as well. jpmorgan declaring edwards the big winner out of the weekend. but we saw a long-term battle. >> what does high good cholesterol not help? >> we are trying to do that. but that's been a big argument. there was a drug raising the good cholesterol. it didn't bear out as well as people thought. there were some side effects people were worried about. that's still a question whether raising hdl is better than lowering ldl or if you should be doing both or what the effects of that are. >> absolutely low cholesterol will lower your risk of getting heart disease. >> that's the picture that is being painted now. >> people have argued whether it's really -- i mean it appears to but then a lot of times clinical trials didn't bear it out. >> we're still getting an understanding of that, i think. >> hereditary too. >> yeah. absolutely. and some of these d
even with lipitor.y. >> well, that's the problem with the blood clot drugs. people are worried about that with brilinta. and then there was news on devices as well. jpmorgan declaring edwards the big winner out of the weekend. but we saw a long-term battle. >> what does high good cholesterol not help? >> we are trying to do that. but that's been a big argument. there was a drug raising the good cholesterol. it didn't bear out as well as people thought. there were some side...
102
102
Mar 16, 2015
03/15
by
CSPAN
tv
eye 102
favorite 0
quote 0
brian: what is the difference between a patented drug like lipitor and then the patent runs out and then you go to the generic? dr. fugh-berman: by the dominant drug comes on the market there are usually seven or 10 years of patent life left. but there are many techniques for extending patent life in some ways of doing that are for example putting out delayed release preparations. a company might do an immediate release and then they do a controlled release and then an extended release. that is a way of extending patent life. sometimes companies will rename drugs and get a new indication for them, sometimes one that they invented. for example prozac was a blockbuster drug and made a lot of money for the company. brian: eli lilly? dr. fugh-berman: eli lilly. so before the patent wore off the company created a condition called pmdd, premenstrual dysphoric disorder. serafim which is prozac. it was indicated for premenstrual disorder and what that meant was even when there was a generic available for prozac there was not a generic available for it even though it is the same drug. that is ano
brian: what is the difference between a patented drug like lipitor and then the patent runs out and then you go to the generic? dr. fugh-berman: by the dominant drug comes on the market there are usually seven or 10 years of patent life left. but there are many techniques for extending patent life in some ways of doing that are for example putting out delayed release preparations. a company might do an immediate release and then they do a controlled release and then an extended release. that is...
193
193
Mar 13, 2015
03/15
by
CNBC
tv
eye 193
favorite 0
quote 0
lipitor will be watching. meg terrell with the details. >> lipitor is an interesting one. there's a huge push to bring a new class of cholesterol drugs to the market. they're made by amgen, and regeneron and pfizer. this week amgen will present data on howell its drug does at reducing the risk of heart attacks and other risks. regeneron and sandfi. fooiz pfizer is competing in the space. they're expected to talk about rejenner rons and amgen's next week. actelion will have a drug for pulmonary hypertension. celexopag will be on the market. the data we see over the weekend could have implications for both of those stocks. lots of activity in both drugs and medical devices at the cardiology conference. it's clearly hard at work on our heart. >> no one pronounces those drugs better than you do. >> i stay up at night. >> sarah, down to you. >> got a big story coming up. robert frank that sounds like a juicy one. >> sara this has everything an arrest in monaco secret storage bunkers, money laundering and billionaires who say they've been defrauded. it's tripping the art world c
lipitor will be watching. meg terrell with the details. >> lipitor is an interesting one. there's a huge push to bring a new class of cholesterol drugs to the market. they're made by amgen, and regeneron and pfizer. this week amgen will present data on howell its drug does at reducing the risk of heart attacks and other risks. regeneron and sandfi. fooiz pfizer is competing in the space. they're expected to talk about rejenner rons and amgen's next week. actelion will have a drug for...
100
100
Mar 16, 2015
03/15
by
BLOOMBERG
tv
eye 100
favorite 0
quote 0
does make mean one of these drugs will be the new lipitor? guest: exactly. this is the excitement after coming out with these drugs. because it's a high patient population in the u.s. we know heart disease is one of the largest killers in the u.s. even if you restrict these drugs to the severe patients which is where the clinical trials are going after, it is a big population. they are calling for the drugs to hit blockbuster status within two years of launching in the market. not as sexy as the hepatitis c sales we've seen but still up, it's a big market. olivia: what are we talking about in terms of the forecast what is the peak revenue for amgen? guest: it's hard to say just yet because to hit the big sweet spot we'll have to see outcomes trials and that's what's coming in 2017, we should see the responses to that. brendan: what is being discussed in "the new england journal of medicine," that's like being on the rolling stone? guest: you really make it when you get it on "the new england journal" of medicine. this is a dogfight between two companies and
does make mean one of these drugs will be the new lipitor? guest: exactly. this is the excitement after coming out with these drugs. because it's a high patient population in the u.s. we know heart disease is one of the largest killers in the u.s. even if you restrict these drugs to the severe patients which is where the clinical trials are going after, it is a big population. they are calling for the drugs to hit blockbuster status within two years of launching in the market. not as sexy as...
189
189
Mar 16, 2015
03/15
by
CNBC
tv
eye 189
favorite 0
quote 0
. >> lipitor the biggest selling drug went anyericgeneric. >> these are injectables.e of the big questions. these could cost they say $100 billion to the u.s. health care system. the drug industry says no. >> in terms of the side effects so far, the days are early in terms of the studies on this but it looked like the sanofi regeneron drugs had worse side effects. >> they look similar. one of the things people worry about are neurocognitive effects with the heart drugs. there's some question of how severe those are and they're going to be continuing to look at them over the long term. right now sfoex arefolks are focused on the efficacy. >> brian? >> i was just saying i know that meg can't hear me but i'm going to pose this to you, melissa. a lot of people talk about "b," the bubble word. i don't know if there's a bubble in anything but i will say this. as you talked, i ran a screener quickly. i have 40 biotechs on my screen with market caps above $500 million, 32 of them are higher year-to-date and 15 of them are up double digits. what a run for biotech. is there a b
. >> lipitor the biggest selling drug went anyericgeneric. >> these are injectables.e of the big questions. these could cost they say $100 billion to the u.s. health care system. the drug industry says no. >> in terms of the side effects so far, the days are early in terms of the studies on this but it looked like the sanofi regeneron drugs had worse side effects. >> they look similar. one of the things people worry about are neurocognitive effects with the heart drugs....
129
129
Mar 11, 2015
03/15
by
CNBC
tv
eye 129
favorite 0
quote 0
lipitor. i don't know if it works. >> you have to pop it if you go to barkley prime. always pop it.e that. used to be commerce. >> doesn't really help to pop it with the steak. red wine, though, very good. opening bell five minutes away on this very busy wednesday. stay with us. we're back right after this. ( yawn ) bulldog: i just had a dream i was at mattress discounters with tempur-pedic and the largest selection of memory foam mattresses under one roof! icomfort by serta... posturepedic hybrid... ( yawn ) comforpedic by beautyrest... oooh! 48 months interest-free financing, free delivery, and queen size memory foam mattress sets as low as $697! that's more mattresses than you can shake a bone at! ♪ mattress discounters ♪ say you're a finance guy. a farmer. a researcher. you used to depend on experience. the internet. your gut. today you can use ibm watson analytics. it can make sense of all kinds of data. uncover hidden correlations and new opportunities. and give recommendations with more confidence on who will buy. what to make. where to plant. which helps you make smarter dec
lipitor. i don't know if it works. >> you have to pop it if you go to barkley prime. always pop it.e that. used to be commerce. >> doesn't really help to pop it with the steak. red wine, though, very good. opening bell five minutes away on this very busy wednesday. stay with us. we're back right after this. ( yawn ) bulldog: i just had a dream i was at mattress discounters with tempur-pedic and the largest selection of memory foam mattresses under one roof! icomfort by serta......
402
402
Mar 5, 2015
03/15
by
WCAU
tv
eye 402
favorite 0
quote 0
non-die pettic men for six years and found those being treated with statens, including zocor and lipitor had a higher risk. >>> a big change at the big top. ring ling brothers and barnum paley circus says it will phase out using elephants in its performances pie 2018. ring ling's elephants have been at the center of lawsuit pies animal rights activist. ringling brothers parent company calls the decision difficult. the circus will keep featuring other animals. >>> forget the peanuts and cracker jacks when you go to the ballpark this spring how about crab agriculture row dog instead? available at arizona diamondbacks' games much the churro dog is a warm cinnamon churro inside a chocolate-glazed doughnut toppe in just this one moment, your baby is getting even more than clean. the scent, the lather, even the tiny bubbles of a johnson's® bath are helping to enhance the experience. the touch of your hands is stimulating her senses. nurturing her mind. and helping her development. so why just clean your baby when you can give her... so much more™? johnson's®. so much more™. i'll never look bac
non-die pettic men for six years and found those being treated with statens, including zocor and lipitor had a higher risk. >>> a big change at the big top. ring ling brothers and barnum paley circus says it will phase out using elephants in its performances pie 2018. ring ling's elephants have been at the center of lawsuit pies animal rights activist. ringling brothers parent company calls the decision difficult. the circus will keep featuring other animals. >>> forget the...